肝脏
肝髒
간장
CHINESE HEPATOLOGY
2014年
11期
844-846
,共3页
经继生%汪顺才%马洁%朱梦琪%马久明%周华%虞腊青%杨永峰
經繼生%汪順纔%馬潔%硃夢琪%馬久明%週華%虞臘青%楊永峰
경계생%왕순재%마길%주몽기%마구명%주화%우석청%양영봉
磷酯酰肌醇蛋白聚糖3%高尔基体蛋白73%HCC%筛查
燐酯酰肌醇蛋白聚糖3%高爾基體蛋白73%HCC%篩查
린지선기순단백취당3%고이기체단백73%HCC%사사
gpc3%gp73%HCC%Screen
目的:评价血清磷酯酰肌醇蛋白聚糖3(gpc3)和高尔基体蛋白73(gp73)的检测对肝细胞癌(HCC)的筛查作用。方法采集70例 HCC 癌及肝硬化(肝脏再生结节)患者基线时外周血。应用 ELISA 法检测患者血清 gpc3和gp73,并与其血清AFP水平做对照。结果 HCC组gpc3、gp73测量值显著高于肝硬化组(P<0.01);gpc3诊断HCC的截断值>9.3μg/L,AUC=0.956,灵敏度为89.74%,特异度为96.77%,阳性预测值为97.2%,阴性预测值为88.2%,约登指数为0.8652,阳性似然比27.82,阴性似然比0.11,gp73诊断 HCC 的截断值>77.68μg/L,AUC=0.937,灵敏度为92.31%,特异度为83.87%,阳性预测值为87.8%,阴性预测值为89.7%,约登指数0.7618,阳性似然比5.72,阴性似然比0.092。结论血清gpc3与gp73水平可用于 HCC的筛查。
目的:評價血清燐酯酰肌醇蛋白聚糖3(gpc3)和高爾基體蛋白73(gp73)的檢測對肝細胞癌(HCC)的篩查作用。方法採集70例 HCC 癌及肝硬化(肝髒再生結節)患者基線時外週血。應用 ELISA 法檢測患者血清 gpc3和gp73,併與其血清AFP水平做對照。結果 HCC組gpc3、gp73測量值顯著高于肝硬化組(P<0.01);gpc3診斷HCC的截斷值>9.3μg/L,AUC=0.956,靈敏度為89.74%,特異度為96.77%,暘性預測值為97.2%,陰性預測值為88.2%,約登指數為0.8652,暘性似然比27.82,陰性似然比0.11,gp73診斷 HCC 的截斷值>77.68μg/L,AUC=0.937,靈敏度為92.31%,特異度為83.87%,暘性預測值為87.8%,陰性預測值為89.7%,約登指數0.7618,暘性似然比5.72,陰性似然比0.092。結論血清gpc3與gp73水平可用于 HCC的篩查。
목적:평개혈청린지선기순단백취당3(gpc3)화고이기체단백73(gp73)적검측대간세포암(HCC)적사사작용。방법채집70례 HCC 암급간경화(간장재생결절)환자기선시외주혈。응용 ELISA 법검측환자혈청 gpc3화gp73,병여기혈청AFP수평주대조。결과 HCC조gpc3、gp73측량치현저고우간경화조(P<0.01);gpc3진단HCC적절단치>9.3μg/L,AUC=0.956,령민도위89.74%,특이도위96.77%,양성예측치위97.2%,음성예측치위88.2%,약등지수위0.8652,양성사연비27.82,음성사연비0.11,gp73진단 HCC 적절단치>77.68μg/L,AUC=0.937,령민도위92.31%,특이도위83.87%,양성예측치위87.8%,음성예측치위89.7%,약등지수0.7618,양성사연비5.72,음성사연비0.092。결론혈청gpc3여gp73수평가용우 HCC적사사。
Objective To evaluate the effects of phosphatidylinositol proteoglycan 3 (GPC3 )and Golgi protein 73 (GP73)levels on screen of early primary hepatocellular carcinoma (HCC). Methods Seventy patients with HCC or liver cirrhosis (hepatic regenerative nodules)were enrolled. GPC3 and GP73 from peripheral serum were assessed by ELISA at baseline,and the relationships between GPC3/GP73 and liver histology/AFP were analyzed,respectively. Results GPC3 and GP73 levels in liver cancer group were significantly higher than those in liver cirrhosis group (P< 0.001);for GPC3, the cut-off value for HCC was 9.3 μg/l (AUC= 0.956). Relevant indexes included sensitivity (89.74% ),specificity (96.77% ),positive predictive value (97.2% ),negative predictive value (88.2% ),the Youden's index (0.8652),positive likelihood ratio (AUC= 0.956,+LR,27.82),and negative likelihood ratio (-LR,0.11);for GP73,the cut-off value was 77.68 ng/ml (AUC= 0.937)with sensitivity of 92.31% ,specificity of 83.87% ,positive predictive value of 87.8% , negative predictive value of 89.7% ,the Youden index of 0.7618,positive likelihood ratio (AUC= 0.937,+LR)of 5.72 and negative likelihood ratio (-LR)of 0.092. Conclusion GPC3 and GP73 levels can be used for screening early HCC.